We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
+1.76%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$1.41B
AUM Growth
+$140M
Cap. Flow
+$151M
Cap. Flow %
10.75%
Top 10 Hldgs %
8.08%
Holding
2,051
New
446
Increased
504
Reduced
559
Closed
528

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$6.69M
2
C icon
Citigroup
C
+$6.01M
3
TRIP icon
TripAdvisor
TRIP
+$5.94M
4
VPHM
VIROPHARMA INC
VPHM
+$5.33M
5
WELL icon
Welltower
WELL
+$5.33M

Sector Composition

Rank Sector Weight
1 Healthcare 15.61%
2 Technology 11.5%
3 Industrials 10.6%
4 Consumer Discretionary 10.6%
5 Energy 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
H icon
1651
Hyatt Hotels
H
$16.4B
-21,370
Closed -$1.06M
HCA icon
1652
HCA Healthcare
HCA
$86.8B
-7,098
Closed -$339K
HCKT icon
1653
Hackett Group
HCKT
$284M
-17,568
Closed -$109K
HEI icon
1654
HEICO Corp
HEI
$51.4B
-15,295
Closed -$363K
HIG icon
1655
Hartford Financial Services
HIG
$38.9B
-19,386
Closed -$702K
HLF icon
1656
Herbalife
HLF
$1.33B
-24,528
Closed -$965K
HNI icon
1657
HNI Corp
HNI
$3.49B
-5,679
Closed -$221K
HPQ icon
1658
HP
HPQ
$26.4B
-131,728
Closed -$1.67M
HRL icon
1659
Hormel Foods
HRL
$13.9B
-89,020
Closed -$2.01M
STRR
1660
Star Equity Holdings
STRR
$40.6M
-2,066
Closed -$83K
HUBG icon
1661
HUB Group
HUBG
$2.92B
-14,184
Closed -$283K
IART icon
1662
Integra LifeSciences
IART
$1.39B
-15,662
Closed -$305K
IBOC icon
1663
International Bancshares
IBOC
$4.74B
-8,296
Closed -$219K
ICUI icon
1664
ICU Medical
ICUI
$4.3B
-4,120
Closed -$262K
IDCC icon
1665
InterDigital
IDCC
$8.34B
-24,247
Closed -$715K
IDXX icon
1666
Idexx Laboratories
IDXX
$46.4B
-21,304
Closed -$1.13M
IFF icon
1667
International Flavors & Fragrances
IFF
$20.7B
-5,729
Closed -$493K
INTC icon
1668
Intel
INTC
$509B
-26,110
Closed -$678K
INTU icon
1669
Intuit
INTU
$88.5B
-30,626
Closed -$2.34M
IOSP icon
1670
Innospec
IOSP
$2.14B
-9,357
Closed -$432K
IPAR icon
1671
Interparfums
IPAR
$4.12B
-6,687
Closed -$239K
IRM icon
1672
Iron Mountain
IRM
$37.3B
-11,523
Closed -$323K
IRWD icon
1673
Ironwood Pharmaceuticals
IRWD
$709M
-17,748
Closed -$173K
ITRI icon
1674
Itron
ITRI
$4.65B
-22,768
Closed -$943K
IVZ icon
1675
Invesco
IVZ
$14.1B
-26,096
Closed -$950K

Similar funds

GSA Capital Partners's Q1 2014 Portfolio in Review

As of Q1 2014, GSA Capital Partners held 2,051 positions worth $1.41B, up 11% from $1.27B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

GSA Capital Partners deployed $151M of net new capital in Q1 2014, opening 446 new positions and adding to 504 existing holdings. Its largest new stake was Alphabet (Google) Class C: 527,450 shares worth $14.6M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Citigroup, an estimated $6.01M trimmed.

  • GSA Capital Partners's largest Q1 2014 buy was Alphabet (Google) Class C: 527,450 shares worth $14.6M.
  • GSA Capital Partners added most to Micron Technology in Q1 2014, an estimated $12.3M increase.
  • GSA Capital Partners's biggest Q1 2014 reduction was Citigroup, cutting an estimated $6.01M.
  • GSA Capital Partners fully exited Pfizer in Q1 2014, selling an estimated $6.69M.
  • GSA Capital Partners's ten largest holdings make up 8.1% of its $1.41B portfolio in Q1 2014.
  • GSA Capital Partners opened 446 new positions and closed 528 in Q1 2014.
  • GSA Capital Partners's portfolio value rose 11% quarter-over-quarter to $1.41B.

Based on GSA Capital Partners's 13F filing for Q1 2014, filed 14 May 2014.